The Latin American dialysis equipment market size is estimated to grow USD 4.27 billion by 2027 from USD 2.93 billion in 2022, growing at a CAGR of 7.8% from 2022 to 2027.
Dialysis machines are used as a substitute for kidneys for purifying blood if kidneys couldn’t filter the blood. These machines cleanse the blood, fills it with vital substances, and remove excess liquid. These machines are permanent in case the patient is not suitable for a kidney transplant.
The prevalence of chronic kidney disease (CRF), worsened by the geriatric population and increasing life expectancy, is expected to drive demand for hemodialysis, accelerating the growth rate of the Latin American dialysis equipment market primarily. The Latin American region is characterized by a growing population and an increasing incidence of various diseases. The United Nations projects that the proportion of the Latin American population aged 65 and over will triple by the middle of the century, from 6.5% in 2005 to 21.5% in 2055. In addition, several countries in Latin America, including Brazil, Chile, and Mexico, may have populations older than the United States in the near future. Another factor influencing the growth of the market is the expansion of the patient group.
Supportive government initiatives and increased healthcare funding to increase awareness of treatment modalities are also expected to boost equipment sales during the forecast period. In addition, the introduction of technologically advanced and user-friendly dialysis equipment and the adoption of kidney dialysis instead of kidney transplantation are key trends impacting the market.
A rapidly growing number of dialysis centers and hospitals in developing countries, combined with an increasing number of patient treatments, is expected to fuel the evolution of new dialysis equipment to drive the dialysis equipment market in Latin America during the forecast period.
Restricted reimbursement is a major restraining factor for the Latin American dialysis equipment market growth. In contrast, many other factors include the lack of awareness of kidney disease, the evolution of small and medium enterprises in the highly competitive market, and the complications and risks of dialysis.
Constant innovation in the dialysis equipment market generates innovation and leads to creating complex systems to which patients and doctors alike find it hard to get used. This is the biggest challenge in the market, and it can only be tackled based on educational training and the introduction of ease of accessibility in equipment.
This research report on the Latin America Dialysis Equipment Market has been segmented and sub-segmented into the following categories:
Based on type, the dialyzers segment is expected to experience the fastest growth during the forecast period. On the other hand, the peritoneal dialysis equipment segment is expected to be another lucrative segment and forecasted to witness a CAGR of 18% by 2027.
By End User:
The demand for renal dialysis equipment in-home care facilities will increase at a higher CAGR than in-center dialysis.
Based on region, Latin America is the third attractive market after North America and Asia-Pacific owing to the growing healthcare infrastructure and growing healthcare expenditure. The Brazilian renal dialysis equipment market is expected to grow at a CAGR of 6.1% during the forecast period. As a result, Brazil accounted for the largest share of the home medical equipment market in Latin America in 2020.
In 2020, Brazil had an estimated incidence rate of 220 cases of end-stage renal disease (ESRD) treated per million population. Hence, with an increasing number of ESRD cases in Brazil, it is driving the growth of the market. Among all these hemodialysis machines, they accounted for the largest share in 2020 and are expected to grow at a high CAGR during the forecast period.
KEY MARKET PLAYERS:
Some of the noteworthy companies leading the Latin America dialysis equipment market profiled in the report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Hemodialysis Equipment
22.214.171.124 Hemodialysis Machines
126.96.36.199 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
188.8.131.52 Continuous Cycling Peritoneal Dialysis
184.108.40.206 Continuous Ambulatory Peritoneal Dialysis
220.127.116.11 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2.2 In-Center Dialysis
5.2.3 Homecare Dialysis
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Type
126.96.36.199 By End User
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Type
220.127.116.11 By End User
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Type
126.96.36.199 By End User
6.4 Rest of Latin America
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.